These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24050892)

  • 1. Declining use of brachytherapy for the treatment of prostate cancer.
    Mahmood U; Pugh T; Frank S; Levy L; Walker G; Haque W; Koshy M; Graber W; Swanson D; Hoffman K; Kuban D; Lee A
    Brachytherapy; 2014; 13(2):157-62. PubMed ID: 24050892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA: Declining utilization of prostate brachytherapy.
    Andring L; Yoder A; Pezzi T; Tang C; Kumar R; Mahmood U; Walker GV
    Brachytherapy; 2022; 21(1):6-11. PubMed ID: 34420862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.
    Xiang M; Nguyen PL
    Brachytherapy; 2015; 14(6):773-80. PubMed ID: 26489921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy boost for prostate cancer: Trends in care and survival outcomes.
    Glaser SM; Dohopolski MJ; Balasubramani GK; Benoit RM; Smith RP; Beriwal S
    Brachytherapy; 2017; 16(2):330-341. PubMed ID: 28159553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
    Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of care with brachytherapy for cervical cancer.
    Bagshaw HP; Pappas LM; Kepka DL; Tward JD; Gaffney DK
    Int J Gynecol Cancer; 2014 Nov; 24(9):1659-64. PubMed ID: 25251463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.
    Yang DD; Muralidhar V; Nguyen PL; Buzurovic I; Martin NE; Mouw KW; Devlin PM; Trinh QD; Orio PF; King MT
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):904-911. PubMed ID: 29063853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians.
    Valdivieso R; Boehm K; Meskawi M; Larcher A; Tian Z; Parent ME; Wong P; Graefen M; Montorsi F; Sun M; Saad F; Karakiewicz PI
    World J Urol; 2015 Dec; 33(12):1985-91. PubMed ID: 25854524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
    Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery.
    Monda S; Pratsinis M; Lui H; Noel O; Chandrasekar T; Evans CP; Dall'Era MA
    Eur Urol Focus; 2024 May; 10(3):448-453. PubMed ID: 37722954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy.
    Gill BS; Chapman BV; Hansen KJ; Sukumvanich P; Beriwal S
    Brachytherapy; 2015; 14(3):373-9. PubMed ID: 25600451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery associated with increased survival compared to radiation in clinically localized Gleason 9-10 prostate cancer: a SEER analysis.
    Nemirovsky A; Huang H; Al Kibria GM; Naslund M; Siddiqui MM
    World J Urol; 2021 Feb; 39(2):415-423. PubMed ID: 32350585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy vs. external beam radiotherapy for choroidal melanoma: Survival and patterns-of-care analyses.
    Abrams MJ; Gagne NL; Melhus CS; Mignano JE
    Brachytherapy; 2016; 15(2):216-23. PubMed ID: 26846381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the utilization of brachytherapy in cervical cancer in the United States.
    Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection.
    Wattson DA; Chen MH; Moran BJ; Dosoretz DE; Braccioforte MH; Salenius SA; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e773-9. PubMed ID: 22300573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
    Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
    Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy improves outcomes in young men (≤60 years) with prostate cancer: A SEER analysis.
    Ashamalla H; Guirguis A; McCool K; McVorran S; Mattes M; Metzger D; Oromendia C; Ballman KV; Mokhtar B; Tchelebi M; Katsoulakis E; Rafla S
    Brachytherapy; 2017; 16(2):323-329. PubMed ID: 28139417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.